Article
Maternal hepatitis C (HCV) infection and Anti-D immunoglobulin therapy: study testing antibodies, RNA and Genotype of HCV in Baghdad.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians - 1 Oct 2019
Al-Kubaisy Waqar, Daud Suzanna, Al-Kubaisi Mustafa Waseem, Al-Kubaisi Omar Waseem, Abdullah Nik Nairan
Abstract excerpt
Introduction: Hepatitis C virus (HCV) infection is a serious health problem. It is a major contributor to end-stage liver disease. Worldwide, 1-8% of all pregnant women were infected. Women with viral hepatitis may be at an increased risk of pregnancy complications. There are several obstetrics intervention acts as risk factors, which are specific to women pertaining the HCV infection; anti-D immunoglobulin (Ig)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
